KaloBios Pharmaceuticals (NASDAQ:KBIO) disclosed that it had been notified by the NASDAQ Listing Qualification Staff regarding its decision to delist the company's stock from the exchange.
The NASDAQ told the management of KaloBios Pharmaceuticals that...
The stock price of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO, the biopharmaceutical company that previously decided to wind down its operations, surprisingly went up 4,000% over the past six trading days.
Today alone, the shares of KaloBios...